Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
InventisBio Co., Ltd clinical trials
The registry lists 34 studies whose lead sponsor is InventisBio Co., Ltd. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Keep track of what changes. Save the InventisBio Co., Ltd studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to InventisBio Co., Ltd.
- InventisBio Co., Ltd34 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 34 of 34.
- A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy AdultsNot yet recruitingNCT07875842Phase 1
- The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function.RecruitingNCT07715175Phase 1
- A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic FunctionRecruitingNCT07715149Phase 1
- A Study to Evaluate YF087 in Subjects With MSI-H or dMMR Advanced Solid TumorsNot yet recruitingNCT07809607Phase 1
- Study of D-2570 in Subjects With Non-Segmental VitiligoRecruitingNCT07625891Phase 2
- A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT07489885Phase 2
- A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque PsoriasisRecruitingNCT07326813Phase 3
- A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)RecruitingNCT07311200Phase 2
- A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic ArthritisRecruitingNCT07315061Phase 2
- A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast CancerRecruitingNCT06954961Phase 3
- Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque PsoriasisRecruitingNCT07130604Phase 3
- Healthy Volunteer StudyActive, not recruitingNCT07270783Phase 1
- Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid TumorsActive, not recruitingNCT05379946Phase 1/2
- A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT07035041Phase 2
- Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With GoutCompletedNCT05665699Phase 2
- Mass Balance Study of [14C] D-2570Active, not recruitingNCT07411742Phase 1
- Single and Multiple Dose and Food Effect Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-2570 Tablets in Healthy SubjectsCompletedNCT07275775Phase 1
- Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT06278350Phase 2
- Study to Evaluate D-1553 in Subjects With Solid TumorsActive, not recruitingNCT04585035Phase 1/2
- A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553CompletedNCT06105255Phase 1
- Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia PatientsCompletedNCT05504083Phase 2
- Study to Evaluate D-1553 in Subjects With Lung CancerCompletedNCT05383898Phase 1/2
- A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung CancerTerminatedNCT05492045Phase 1/2
- D-0316 in Patients With EGFR Positive Non Small Cell Lung CancerCompletedNCT03861156Phase 2
- Mass Balance Study of [14C] D-1553 in Chinese Healthy Adult Male SubjectsCompletedNCT06233916Phase 1
- A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast CancerCompletedNCT03471663Phase 1
- D-0316 First Time in Patients Ascending Dose StudyCompletedNCT03452150Phase 1
- Study in Healthy Adult Female SubjectsCompletedNCT05339633Phase 1
- Evaluation of PK and Safety of D-0120 and AllopurinolCompletedNCT05360628Early Phase 1
- Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female SubjectsCompletedNCT05226338Phase 1
- D-0120 Safety and PK/PD Study in ChinaCompletedNCT03923868Phase 1/2
- Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy VolunteersCompletedNCT04097405Phase 1
- Food Effect Study of D-0502 Tablet in Healthy VolunteersCompletedNCT03810625Phase 1
- D-0120 Safety and PK/PD, Food Effect Study in Healthy VolunteersCompletedNCT03291782Phase 1